Immuno-nutrition: Designer diets in cancer

Supportive Care in Cancer

Volumn 5, Issue 5, 1997, Pages 381-386

  Imoberdorf, R ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Arginine; Cancer; Designer diets; Glutamine; Immuno nutrition

Indexed keywords

ARGININE; GLUTAMINE; OLIGONUCLEOTIDE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN; RNA;

CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL TRIAL; DIET SUPPLEMENTATION; ENERGY EXPENDITURE; GASTROINTESTINAL SURGERY; HUMAN; HYPERMETABOLISM; METASTASIS; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; REVIEW;

CLINICAL TRIALS; DIET; HUMANS; NEOPLASMS; NUTRITIONAL SUPPORT; PROGNOSIS; WEIGHT LOSS;

EID: 0030759178     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050096     Document Type: Review

References (70)

1. Alexander JW, Saito H, Trocki O (1986) The importance of lipid type in the diet after burn injury. Ann Surg 204:1-8
2. Barbul A (1986) Arginine: biochemistry, physiology, and therapeutic implications. JPEN J Parenter Enteral Nutr 10:227-238
3. Barbul A (1990) Arginine and immune function. Nutrition 6:53-58
4. Baur EM, Greschner LM (1992) Metabolische Untersuchungen an Patienten mit malignen Tumoren. Ruheumsatz, peripherer und tumoraler Substrataustausch. Medical Dissertation, Heidelberg/Mannheim
5. Bozzetti F, Cozzaglio L, Gavazzi C, Brandi S, Bonfanti G, Lattarulo M, Gennari L (1996) Total nutritional manipulation in humans: a report of a cancer patient. Clin Nutr 15:207-209
6. Burke DJ, Alverdy JC, Aoys E, Moss GS (1990) Effect of route of glutamine administration on mortality following experimental enterocolitis. JPEN J Parenter Enteral Nutr 14 [Suppl]:8S
7. Burt ME, Brennan MF (1984) Nutritional support of the patient with esophageal cancer. Semin Oncol 11:127-135
8. Burt ME, Norton JA, Brennan M (1980) The human tumor-bearing limb: an ex vivo model. Surgery 87:128-132
9. Caso G, Matar S, McNurlan MA, McMillan DN, Eremin O, Garlick PJ (1996) Metabolic effects of arginine on malignant tissues. Clin Nutr 15:89-90
10. Chen MK, Salloum RM, Austgen TR, et al (1991) Tumor regulation of hepatic glutamine metabolism. JPEN J Parenter Enteral Nutr 15:159
11. Chiba T, Uchida T, Hayahi Y, et al (1985) Effects of nucleotides on nitrogen metabolism in mammalian tissues. JPEN J Parenter Enteral Nutr 9:118-124
12. Daly JM, Torosian MH (1993) Nutritional support. In: DeVita V, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology. Lippincott, Philadelphia, pp 2480-2501
13. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub FN, Rosato EF, Lavin P (1992) Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: Immunologic, metabolic, and clinical outcome. Surgery 112:56-67
14. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M (1995) Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 221:327-338
15. Déchelotte P (1995) Pharmacological nutrition and immune nutrition in cancer patients. In: Cynober L, Fürst P, Lawin P (eds) Pharmacological nutrition, immune nutrition. Zuckschwerdt, München Bern Wien New York, pp 122-134
16. Delarue J, Lerebours E (1987) Status nutritionnel et métabolique des cancéreux. Gastroentérol Clin Biol 11:558-564
17. DeWys WD, Begg C, Lavin PT, et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69:491-497
18. Emery PW, Edwards RHT, Rennie MJ, Souhami RL, Halliday D (1984) Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J 289:584-586
19. Fahr MJ, Kornbluth J, Blossom S, Schaeffer R, Klimberg VS (1994) Glutamine enhances immunoregulation of tumor growth. JPEN J Parenter Enteral Nutr 18:471-476
20. Fein R, Kelsen DP, Geller N (1985) Adenocarcinoma of the esophagus and gastroesophageal junction: prognostic factors and results of therapy. Cancer 56:2512-2518
21. Fox AD, Kripke SA, DePaula J, Berman JM, Settle RG, Rombeau JL (1988) Effect of glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr 12:325-331
22. Furst P (1994) New parenteral substrates in clinical nutrition. I. Introduction. New substrates in protein nutrition. Eur J Clin Nutr 48:607-616
23. Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295-315
24. Gottschlich M (1992) Selection of optimal lipid sources in enteral and parenteral nutrition. Nutr Clin Pract 7:152-165
25. Gottschlich M, Jenkins M, Warden G, et al (1990) Differential effects of three enteral dietary regimens on selected outcome variables in burn patients. JPEN J Parenter Enteral Nutr 14:225-236
26. Greschner M, Saeger HD, Barth H, Leweling H, Holm E (1991) Balances of energy-yielding substrates across malignant gastric tumors in man. Clin Nutr 10 [Suppl]:12
27. Hagmüller E, Gunther HJ, Brösicke H, Richter A, Striebel SP, Holm E (1993) In vivo studies in man on anabolism of protein metabolism in malignant colon tumors: correlations to pathohistology. Clin Nutr 12 [Suppl 2]:5-6
28. Hagmüller E, Kollmar HB, Günther HJ, Holm E, Trede M (1995) Protein metabolism in human colon carcinomas: in vivo investigations using a modified tracer technique with I-(1-13C)leucine. Cancer Res 55:1160-1167
29. Holm E, Hagmüller E, Staedt U, et al (1995) Substrate balances across colonic carcinomas in humans. Cancer Res 55:1373-1378
30. Janniger CK, Racis SP (1987) The arachidonic acid cascade, an immunologically based review. J Med 18:69-80
31. Jebb SA, Osborne RJ, Maughan TS, Mohideen N, Mack P, Mort D, Shelley MD, Elia M (1994) 5-fluorouracil and folinic acid induced mucositis: no effect of oral glutamine supplementation. Br J Cancer 70:732-735
32. Jeevanandam M, Lowry SF, Horowitz GD, Brennan MF (1984) Cancer cachexia and protein metabolism. Lancet II:1423-1426
33. Jeevanandam M, Horowitz GD, Lowry SF, Brennan MF (1986) Cancer cachexia and the rate of whole body lipolysis in man. Metabolism 35:304-310
34. Karmali RA, Marsh J, Fuchs C (1984) Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst 73:457-461
35. Kemen M, Senkal M, Homann HH, Mumme A, Dauphin AK, Baier J, Windeler J, Neumann H, Zumtobel V (1995) Early postoperative enteral nutrition with arginine, omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of impact. Crit Care Med 23:652-659
36. Kulkarni AD, Fanslow WC, Rudolph FB, et al (1987) Modulation of delayed hypersensitivity in mice by dietary nucleotide restriction. Transplantation 44:847-849
37. Kunkel SL (1988) The importance of arachidonate metabolism by immune and nonimmune cells. Lab Invest 58:119-121
38. Laviano A, Meguid MM (1996) Nutritional issues in cancer management. Nutrition 12:358-371
39. Lundholm K, Bylund AC, Holm J (1976) Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer 12:465-473
40. Lundholm K, Holm G, Schersten T (1978) Insulin resistance in patients with cancer. Cancer Res 38:4665-4670
41. Mertin J, Hunt R (1976) Influence of polyunsaturated fatty acids on survival of skin allografts and tumor incidence in mice. Proc Natl Acad Sci USA 73:928-931
42. Newsholme EA, Crabtree B, Ardawi MSM (1985) Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Q J Exp Physiol 70:473-489
43. Norton JA, Burt ME, Brennan MF (1980) In vivo utilization of substrate by human sarcoma-bearing limbs. Cancer 45:2934-2939
44. Norton JA, Stein TP, Brennan MF (1981) Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer. Ann Surg 194:123-128
45. Oka T, Ohwada K, Nagao M, Kitazato K (1993) Effect of arginine-enriched total parenteral nutrition on the host-tumor interactions in cancer-bearing rats. JPEN J Parenter Enteral Nutr 17:375-383
46. Oka T, Ohwada K, Nagao M, Kitazato K, Kyshino Y (1994) Arginine-enriched solution induces a marked increase in muscle glutamine concentration and enhances muscle protein synthesis in tumor-bearing rats. JPEN J Parenter Enteral Nutr 18:491-496
47. Park KGM, Heys SD, Blessing K, Kelly P, McNurlan MA, Eremin O, Garlick PJ (1992) Stimulation of human breast cancers by dietary 1-arginine. Clin Sci 82:413-417
48. Parker CW (1986) Leukotrienes and prostaglandins in the immune system. Adv Prostaglandin Thromboxane Leukot Res 16:113-134
49. Peck MD (1994) Interaction of lipids with immune function. I. Biochemical effects of dietary lipids on plasma membranes. J Nutr Biochem 5:466-478
50. Peck MD (1994) Interactions of lipids with immune function. II. Experimental and clinical studies of lipids and immunity. J Nutr Biochem 5:514-521
51. Reynolds JV, Daly JM, Zhang S (1988) Immunomodulatory mechanisms of arginine. Surgery 104:142-151
52. Reynolds JV, Daly JM, Shou J, Sigal R, Ziegler MM, Naji A (1990) Immunologic effects of arginine supplementation in tumor-bearing and non-tumor-bearing hosts. Ann Surg 211:202-210
53. Rudolph FB, Kulkarni AD, Schandle VB, et al (1984) Involvement of dietary nucleotides in T lymphocyte function. Adv Exp Med Biol 165B:175-178
54. Salloum RM, Copeland EM III, Bland KI, Souba WW (1991) Selective stimulation of brush border glutamine transport in the tumor-bearing rat. J Surg Res 50:391
55. Schloerp PR, Amare M (1993) Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 17:407-413
56. Senkal M, Kemen M, Homann HH, Eickhof U, Baier J, Zumtobel V (1995) Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 161:115-122
57. Shaw JHF, Wolfe RR (1987) Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 205:368-376
58. Souba WW (1997) Nutritional support. N Engl J Med 336:41-48
59. Souba WW, Smith DR, Wilmore DW (1985) Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr 9:608-617
60. Souba WW, Klimberg SK, Plumley DA, et al (1990) The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res 48:383-319
61. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M (1996) Characterization of a cancer cachectic factor. Nature 379:739-742
62. Van Zaanen HCT, Lelie H van der, Timmer JG, Fürst P, Sauerwein HP (1994) Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity. Cancer 74:2879-2884
63. Wachtler P, Hilger RA, Konig W, Bauer KH, Kemen M, Köller M (1995) Influence of a pre-operative enteral supplementation on functional activities of peripheral leukocytes from patients with major surgery. Clin Nutr 14:275-282
64. Wallace C, Keast D (1992) Glutamine and macrophage function. Metabolism 41:1016-1020
65. Waterhouse C (1974) Lactate metabolism in patients with cancer. Cancer 33:66-71
66. Waymack JP, Rapien J, Garnett ZD, et al (1986) Effect of transfusion on immune function in a traumatized animal model. Arch Surg 121:50-54
67. Waymack JP, Robb E, Alexander JW (1987) Effect of immune function in a traumatized animal model. II. Effect on mortality rate following septic challenge. Arch Surg 122:933-939
68. Ye SL, Istfan NW, Driscoll DF, Bistrian BR (1992) Tumor and host response to arginine and branched-chain amino acid-enriched total parenteral nutrition. A study involving Walker 256 carcinosarcoma-bearing rats. Cancer 69:261-270
69. Ziegler TR (1993) Nutritional complications associated with chemotherapy and irradiation in cancer treatment. In: Wilmore DW, Carpentier YA (eds) Metabolic support of the critically ill patient. Springer, Berlin Heidelberg New York, pp 407-426
70. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, Morrow FD, Jacobs DO, Smith RJ, Antin HJ, Wilmore DW (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 116:821-828